We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+7.55%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$27.9B
AUM Growth
+$4.08B
Cap. Flow
+$2.62B
Cap. Flow %
9.39%
Top 10 Hldgs %
6.03%
Holding
3,311
New
278
Increased
1,671
Reduced
1,018
Closed
254

Sector Composition

Rank Sector Weight
1 Financials 11.11%
2 Industrials 10.08%
3 Technology 9.94%
4 Healthcare 9.76%
5 Consumer Discretionary 9.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CBB
2826
DELISTED
Cincinnati Bell Inc.
CBB
$126K ﹤0.01%
9,249
+4,425
+92% +$70K
IDTI
2827
DELISTED
Integrated Device Technology I
IDTI
$123K ﹤0.01%
13,045
+776
+6% +$6.9K
PMX
2828
DELISTED
PIMCO Municipal Income Fund III
PMX
$122K ﹤0.01%
11,679
-1,772
-13% -$18.3K
UI icon
2829
Ubiquiti
UI
$34.3B
$122K ﹤0.01%
+3,633
New +$97.4K
BCRX icon
2830
BioCryst Pharmaceuticals
BCRX
$2.38B
$121K ﹤0.01%
16,565
-3,467
-17% -$17.6K
TLPH icon
2831
Talphera
TLPH
$74.2M
$120K ﹤0.01%
+558
New +$122K
NWS icon
2832
News Corp Class B
NWS
$18.3B
$119K ﹤0.01%
+7,228
New +$117K
SPRT
2833
DELISTED
support.com, Inc.
SPRT
$119K ﹤0.01%
7,294
-225
-3% -$3.66K
PLXT
2834
DELISTED
PLX TECHNOLOGY INC
PLXT
$119K ﹤0.01%
19,788
-500
-2% -$2.73K
OXSQ icon
2835
Oxford Square Capital
OXSQ
$157M
$118K ﹤0.01%
+12,061
New +$118K
OME
2836
DELISTED
Omega Protein
OME
$117K ﹤0.01%
11,538
+1,148
+11% +$10.7K
AMKR icon
2837
Amkor Technology
AMKR
$13.5B
$112K ﹤0.01%
26,122
+1,019
+4% +$4.37K
KEF
2838
DELISTED
Korea Equity Fund
KEF
$112K ﹤0.01%
12,920
VITC
2839
DELISTED
VITACOST COM INC COM STK (DE)
VITC
$111K ﹤0.01%
+12,995
New +$113K
VVTV
2840
DELISTED
VALUEVISION MEDIA INC
VVTV
$110K ﹤0.01%
25,270
+1,836
+8% +$9.71K
LYTS icon
2841
LSI Industries
LYTS
$913M
$108K ﹤0.01%
12,737
+702
+6% +$5.54K
CWST icon
2842
Casella Waste Systems
CWST
$5.75B
$107K ﹤0.01%
18,549
+1,085
+6% +$5.46K
EGHT icon
2843
8x8 Inc
EGHT
$329M
$106K ﹤0.01%
+10,510
New +$98.2K
OMEX icon
2844
Odyssey Marine Exploration
OMEX
$44M
$106K ﹤0.01%
2,928
-36
-1% -$1.36K
RXII
2845
DELISTED
GALENA BIOPHARMA INC COM
RXII
$105K ﹤0.01%
45,904
+11,084
+32% +$25.4K
ACLS icon
2846
Axcelis
ACLS
$4.2B
$104K ﹤0.01%
12,249
+82
+0.7% +$665
IWS icon
2847
iShares Russell Mid-Cap Value ETF
IWS
$15.8B
$104K ﹤0.01%
1,703
-87
-5% -$5.25K
GPT
2848
DELISTED
Gramercy Property Trust
GPT
$104K ﹤0.01%
8,407
+1,588
+23% +$21K
FLOW
2849
DELISTED
FLOW INTL CORP
FLOW
$103K ﹤0.01%
25,626
+1,105
+5% +$4.09K
CTIC
2850
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$102K ﹤0.01%
6,217
+814
+15% +$9.43K

Similar funds

Guggenheim Capital's Q3 2013 Portfolio in Review

As of Q3 2013, Guggenheim Capital held 3,311 positions worth $27.9B, up 17% from $23.8B the previous quarter. Its ten largest holdings account for 6% of the portfolio.

Guggenheim Capital deployed $2.62B of net new capital in Q3 2013, opening 278 new positions and adding to 1,671 existing holdings. Its largest new stake was State Street SPDR Dow Jones Industrial Average ETF Trust: 806,700 shares worth $122M.

By sector, the portfolio is most concentrated in Financials at 11% of assets, down from 12% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $111M trimmed.

  • Guggenheim Capital's largest Q3 2013 buy was State Street SPDR Dow Jones Industrial Average ETF Trust: 806,700 shares worth $122M.
  • Guggenheim Capital added most to GUGGENGEIM BULLETSHARES 2015 HIGH YIELD CORPORATE BOND ETF in Q3 2013, an estimated $36.6M increase.
  • Guggenheim Capital's biggest Q3 2013 reduction was Invesco QQQ Trust, cutting an estimated $111M.
  • Guggenheim Capital fully exited PIMCO Enhanced Short Maturity Active Exchange-Traded Fund in Q3 2013, selling an estimated $60.8M.
  • Guggenheim Capital's ten largest holdings make up 6% of its $27.9B portfolio in Q3 2013.
  • Guggenheim Capital opened 278 new positions and closed 254 in Q3 2013.
  • Guggenheim Capital's portfolio value rose 17% quarter-over-quarter to $27.9B.

Based on Guggenheim Capital's 13F filing for Q3 2013, filed 14 Nov 2013.